Questioning FDA Oversight

John Abramson sheds light on the FDA's role in supervising drug companies, revealing that their primary focus is on determining if a drug provides more benefit than harm. He also discusses the lack of correction of misrepresented data in medical journals, raising concerns about the FDA's role in censorship and suppression.